- Patent Title: Inhibitors of type 2 vascular endothelial growth factor receptors
-
Application No.: US15070572Application Date: 2016-03-15
-
Publication No.: US09862758B2Publication Date: 2018-01-09
- Inventor: Yan Chen , Elena Getmanova , Martin C. Wright , Alan S. Harris , Ai Ching Lim , Jochem Gokemeijer , Lin Sun , Michael Wittekind
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: BRISTOL-MYERS QUIBB COMPANY
- Current Assignee: BRISTOL-MYERS QUIBB COMPANY
- Current Assignee Address: US NJ Princeton
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane. E. Remillard, Esq.; Christopher L. Frank
- Main IPC: C07K14/78
- IPC: C07K14/78 ; C07H21/04 ; C12N15/09 ; C07K19/00 ; C07K14/47 ; C07K14/52 ; C07K16/28 ; C07K16/30 ; A61K38/39 ; A61K38/00 ; A61K39/00
Abstract:
The present disclosure relates to novel vascular endothelial growth factor receptor (VEGFR)-binding polypeptides and methods for using these polypeptides to inhibit biological activities mediated by vascular endothelial growth factors (VEGFs). The present disclosure also provides various improvements relating to single domain binding polypeptides.
Public/Granted literature
- US20160297869A1 INHIBITORS OF TYPE 2 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS Public/Granted day:2016-10-13
Information query
